Results
|
6861.
|
|
|
6862.
|
|
|
6863.
|
|
|
6864.
|
|
|
6865.
|
|
|
6866.
|
Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. [electronic resource] by
- Klintmalm, G B
- Goldstein, R
- Gonwa, T
- Wiesner, R H
- Krom, R A
- Shaw, B W
- Stratta, R
- Ascher, N L
- Roberts, J W
- Lake, J
Producer: 19930325
In:
Transplantation proceedings vol. 25
Availability: No items available.
|
|
6867.
|
|
|
6868.
|
Nephrotoxicity of FK 506 and cyclosporine when used as primary immunosuppression in liver transplant recipients. [electronic resource] by
- Porayko, M K
- Textor, S C
- Krom, R A
- Hay, J E
- Gores, G J
- Wahlstrom, H E
- Sanchez-Urdazpal, L
- Richards, T
- Crotty, P
- Beaver, S
Producer: 19930325
In:
Transplantation proceedings vol. 25
Availability: No items available.
|
|
6869.
|
|
|
6870.
|
|
|
6871.
|
|
|
6872.
|
|
|
6873.
|
|
|
6874.
|
|
|
6875.
|
|
|
6876.
|
|
|
6877.
|
|
|
6878.
|
|
|
6879.
|
|
|
6880.
|
|